TGen Clinical Research Services

Category: Research, Testing, & Medical Laboratories (including CROs)

With nearly 30 active clinical trials for advanced and/or rare cancers, TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types. Further development of cancer specific divisions in pancreatic cancer, breast cancer, leukemia, prostate cancer, lung cancer, and melanoma are under development.

In addition to clinical trials, a molecular profiling pilot study has been designed and implemented to test the hypothesis that treatment with a cancer agent selected based on the unique molecular profile of a patient's tumor may be more beneficial than a treatment selected based on the specific cancer type.

Patient participation in clinical trials is a necessary component to the research process. According to the National Institutes for Health, only 3% of adults with cancer are participating in clinical trials. At TCRS, the clinical trial participation rate is a remarkable 60%. Interestingly, a recent study shows that if given the opportunity and access to clinical trials, 63% of the population would participate, according to a survey by the Charlton Research Co.

Patient participation in clinical trials at TCRS includes:

- 125 visits per month

- 35-45 new patients per month

- 400-600 patient samples collected per month

For ALL patients inquiring about a particular study, please contact patient care coordinator, Joyce Ingold.

Joyce Ingold RN MSN OCN
TGen Clinical Research Services @ SHC
jingold@shc.org